{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:44:51Z","timestamp":1761169491074,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jval.2022.06.006","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T07:50:35Z","timestamp":1660204235000},"page":"1863-1870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association Between Receipt of Definitive Treatment for Localized Prostate Cancer and Adverse Health Outcomes: A Claims-Based Approach"],"prefix":"10.1016","volume":"25","author":[{"given":"Jean M.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole Roan","family":"Gresenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jval.2022.06.006_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.jval.2022.06.006_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer","volume":"367","author":"Wilt","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jval.2022.06.006_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.jval.2022.06.006_bib4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.jval.2022.06.006_bib5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.2017.1652","article-title":"Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer","volume":"317","author":"Chen","year":"2017","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.jval.2022.06.006_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jval.2022.06.006_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.eururo.2014.08.074","article-title":"Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry","volume":"68","author":"Punnen","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.jval.2022.06.006_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2015.11.035","article-title":"Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer","volume":"118","author":"Zelefsky","year":"2016","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.jval.2022.06.006_bib9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jama.2017.1704","article-title":"Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years","volume":"317","author":"Barocas","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jval.2022.06.006_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.2019.20675","article-title":"Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.jval.2022.06.006_bib11","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/jnci\/djq393","article-title":"Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data","volume":"102","author":"Hadley","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"22","key":"10.1016\/j.jval.2022.06.006_bib12","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1001\/jama.296.22.2683","article-title":"Survival associated with treatment vs observation of localized prostate cancer in elderly men","volume":"296","author":"Wong","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jval.2022.06.006_bib13","doi-asserted-by":"crossref","first-page":"e814","DOI":"10.1016\/j.clgc.2019.05.005","article-title":"Active surveillance versus radical prostatectomy in favorable-risk localized prostate cancer","volume":"17","author":"Thomsen","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.jval.2022.06.006_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fonc.2017.00185","article-title":"Propensity score matched comparison of intensity modulated radiation therapy vs stereotactic body radiation therapy for localized prostate cancer: a survival analysis from the National Cancer Database","volume":"7","author":"Ricco","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.jval.2022.06.006_bib15","article-title":"Casual inference methods for selection on observed and unobserved factors: propensity score matching, Heckit models and instrumental variable estimation","volume":"24","author":"Scott","year":"2019","journal-title":"Pract Assess Res Eval"},{"issue":"12","key":"10.1016\/j.jval.2022.06.006_bib16","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J\u00a0Clin Epidemiol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301522020435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301522020435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:26:23Z","timestamp":1761096383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301522020435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1098301522020435"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2022.06.006","relation":{},"ISSN":["1098-3015"],"issn-type":[{"type":"print","value":"1098-3015"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Receipt of Definitive Treatment for Localized Prostate Cancer and Adverse Health Outcomes: A Claims-Based Approach","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2022.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}